Last reviewed · How we verify

NCT05956717

The Effect of Orthokeratography on the Quality of Life and Behavior of Myopic Children

Status unknown Last updated 21 July 2023
What this trial tests

trial testing Orthokeratology in Myopia in 60 participants. Status unknown.

Timeline
1 May 2022
Primary endpoint
31 December 2023
1 October 2024

Quick facts

Lead sponsorTianjin Eye Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment60
Start date1 May 2022
Primary completion31 December 2023
Estimated completion1 October 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Tianjin Eye Hospital

Who can join

Adults 8 to 18, any sex, with Myopia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study intended to observe the changes in the quality of life, behavior, and eye habits of children and adolescents aged 8-18 years before and after orthokeratology, as well as the differences in the quality of life and behaviors of different myopic groups after keratoplasty, using the EQ-5D-Y, CHU9D, and CHROME-G scales with the use of a self-assessment method.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Orthokeratology

Trials testing the same drug.

Other recruiting trials for Myopia

Currently open trials in the same condition.

Other Tianjin Eye Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05956717.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing